Led · Seed · Aug 2026

formX offers an AI-native platform that automates and coordinates design, engineering, planning, permitting, procurement, and construction workflows while allowing each home to remain fully customized. The company emphasizes standardizing the process behind residential projects rather than standardizing the homes themselves. Its platform is already deployed on residential projects in the San Francisco Bay Area. formX plans to use the Seed funding to accelerate product development and expand its engineering team. The company also intends to scale its technology more broadly across California. Founders named in the announcement are Gal Rozensweig, Shay Hasson, and Nami Gheidar. The announcement did not disclose revenue or user metrics.

Participated · Series A · Jun 2026

Limitless Labs builds a Physical AI Foundation Model trained on metal cutting physics, CAD geometry, and machine constraints to power a CAM Agent that automates CNC programming inside CAD/CAM systems like Mastercam, Siemens NX, and PTC Creo. The CAM Agent identifies features, recommends tools and operation sequences, generates toolpaths, and produces shop-floor-ready programs while keeping engineers in control. Customers claim the platform can reduce CNC programming time by up to 50%, and the company has production deployments with Blue Origin, Cadillac F1, Sandvik, and Iscar. The platform supports deployment across cloud, private VPC, and AWS GovCloud and is ITAR-compliant for regulated industries. Financially, the company has raised $27.3 million to date, including a $20 million Series A announced in June 2026. Planned uses of recent funding include U.S. commercial expansion, advancing closed-loop CNC automation, growing the CAM Agent, expanding the Tel Aviv research lab, and roughly doubling headcount over the next year.

Led · Series A · Mar 2026

Scala Biodesign builds ScalaOS, a production-grade protein design platform that integrates physics-based modeling, evolutionary data, and LLM-based AI models to optimize protein performance. The platform targets applications across antibodies, enzymes, vaccines, diagnostics, and industrial biotechnology, and aims to reduce experimental iterations by producing higher-performing designs often in a single design cycle. Over the past eight months ScalaOS has onboarded nine of the world’s top 20 pharmaceutical companies and engaged leading chemical corporations. A highlighted collaboration with Boehringer Ingelheim reportedly stabilized multiple challenging drug targets, improving expression and activity to advance discovery programs. Scala was founded in 2022 by Dr. Ravit Netzer and Dr. Adi Goldenzweig, with Chief Scientist Prof. Sarel Fleishman, and is based in Tel Aviv, Israel. The company has translated more than a decade of validated protein design research and 150+ publications into an enterprise-ready software platform for industry R&D.

Participated · Series C · Mar 2026

NoTraffic develops an AI-powered mobility platform that connects and optimizes traffic signals as a cloud-based digital grid to improve efficiency, sustainability, and safety. The company operates a proactive Operations Center offering 24/7 monitoring, remote diagnostics, and over-the-air updates to support agency teams and deployments. Its platform has been adopted by traffic agencies across more than 40 U.S. states and Canada, including deployments in Houston, Phoenix, and Oklahoma. The company is led by CEO Tal Kreisler and is based in Overland Park, KS. Financially, NoTraffic recently completed a $90M Series C to fund expansion of operations and further product development.

Participated · Seed · Mar 2026

Niv-AI has developed an AI platform that links electricity consumption to computing workloads, aiming to help data centers use power more efficiently. The company's technology matches computing tasks with available electrical capacity to optimize energy use. Public reporting on the company centers on its recent Seed raise and investor syndicate rather than operational metrics. There are no reported revenue, user, or other key operating figures in the articles. The company raised $12 million in Seed funding to support its next stage of development. Additional details on future product plans or specific go-to-market initiatives were not disclosed in the coverage.